MX2019008116A - Proceso para la preparacion de compuestos de 5-amino-6h-tiazolo[4, 5-d]pirimidina-2,7-diona 3-sustituidos. - Google Patents
Proceso para la preparacion de compuestos de 5-amino-6h-tiazolo[4, 5-d]pirimidina-2,7-diona 3-sustituidos.Info
- Publication number
- MX2019008116A MX2019008116A MX2019008116A MX2019008116A MX2019008116A MX 2019008116 A MX2019008116 A MX 2019008116A MX 2019008116 A MX2019008116 A MX 2019008116A MX 2019008116 A MX2019008116 A MX 2019008116A MX 2019008116 A MX2019008116 A MX 2019008116A
- Authority
- MX
- Mexico
- Prior art keywords
- iazolo
- pyrimidine
- amino
- substituted
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
La presente invención se refiere a un proceso para sintetizar un compuesto de fórmula (I), (I),(ver formula) R1 es H o alquilo C1-6; R2 es H o hidroxi; o una sal o diastereómero farmacéuticamente aceptable, que es útil para la profilaxis y el tratamiento de una enfermedad viral en un paciente relacionada con infección por hepatitis B o una enfermedad causada por infección por hepatitis B.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2017070437 | 2017-01-06 | ||
CN2017112149 | 2017-11-21 | ||
PCT/EP2018/050159 WO2018127525A1 (en) | 2017-01-06 | 2018-01-04 | PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED 5-AMINO-6H-THIAZOLO[4,5-d]PYRIMIDINE-2,7-DIONE COMPOUNDS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019008116A true MX2019008116A (es) | 2019-09-04 |
Family
ID=60953862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019008116A MX2019008116A (es) | 2017-01-06 | 2018-01-04 | Proceso para la preparacion de compuestos de 5-amino-6h-tiazolo[4, 5-d]pirimidina-2,7-diona 3-sustituidos. |
Country Status (12)
Country | Link |
---|---|
US (1) | US11142534B2 (es) |
EP (1) | EP3568400A1 (es) |
JP (2) | JP7201598B2 (es) |
KR (1) | KR102602328B1 (es) |
CN (1) | CN110139868B (es) |
AU (2) | AU2018205994B2 (es) |
BR (1) | BR112019013884A2 (es) |
CA (1) | CA3048768A1 (es) |
IL (1) | IL267801B2 (es) |
MX (1) | MX2019008116A (es) |
TW (1) | TWI808068B (es) |
WO (1) | WO2018127525A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3048771A1 (en) * | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | Solid forms of [(1s)-1-[(2s,4r,5r)-5-(5-amino-2-oxo-thiazolo[4,5-d]p yrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate |
CA3048768A1 (en) * | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds |
US12012421B2 (en) | 2017-07-07 | 2024-06-18 | Hoffmann-La Roche Inc. | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate |
US12012420B2 (en) | 2017-11-21 | 2024-06-18 | Hoffmann-La Roche, Inc. | Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetate |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5476659A (en) | 1982-11-09 | 1995-12-19 | The Scripps Research Institute | Cancerous B cell treatment using substituted nucleoside derivatives |
US5166141A (en) | 1983-11-01 | 1992-11-24 | Scripps Clinic And Research Foundation | Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals |
US5041426A (en) | 1987-12-21 | 1991-08-20 | Brigham Young University | Immune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotides |
FR2668153B1 (fr) * | 1990-10-22 | 1995-03-31 | Pasteur Merieux Serums Vacc | Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant. |
EP1072607A3 (en) | 1996-10-16 | 2001-09-12 | ICN Pharmaceuticals, Inc. | Purine L-nucleosides, analogs and uses therof |
KR100412480B1 (ko) | 1996-10-16 | 2003-12-31 | 아이씨엔 파마슈티컬스, 인코포레이티드 | 푸린 l-누클레오시드, 이의 유사체 및 이들의 용도 |
US20050004144A1 (en) | 2003-04-14 | 2005-01-06 | Regents Of The University Of California | Combined use of IMPDH inhibitors with toll-like receptor agonists |
ATE465742T1 (de) | 2003-09-05 | 2010-05-15 | Anadys Pharmaceuticals Inc | Tlr7-liganden zur behandlung von hepatitis c |
ES2525567T3 (es) | 2004-12-17 | 2014-12-26 | Anadys Pharmaceuticals, Inc. | Compuestos de 3H-oxazolo y 3H-tiazolo[4,5-d]pirimidin-2-ona 3,5-disustituidos y 3,5,7-trisustituidos y profármacos de los mismos |
BRPI0618789A2 (pt) | 2005-11-21 | 2016-08-30 | Anadys Pharmaceuticals Inc | processos de preparação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-ona, de ciclocondensação de 2,4-diamino-5-halo-pirimidina e de oxidação de 5-amino-3h-tiazol [4,5-d] pirimidin-2-tiona |
AR061024A1 (es) | 2006-05-22 | 2008-07-30 | Novartis Ag | Maleato de 5-amino-3- (2'3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d] pirimidin-2-ona. |
DE602007012247D1 (de) | 2006-06-22 | 2011-03-10 | Anadys Pharmaceuticals Inc | Prodrugs von 5-amino-3-(3'-deoxy-beta-d-ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion |
BRPI0714831A2 (pt) | 2006-07-18 | 2013-04-02 | Anadys Pharmaceuticals Inc | composto, composiÇço farmacÊutica e mÉtodos de modulaÇço de atividades imuno da citoquina em paciente, de tratamento de infecÇço de vÍrus c da hepatite em paciente e de desordem relacionada com proliferaÇço em mamÍfero necessitado do mesmo |
BRPI0717741A2 (pt) | 2006-10-17 | 2014-04-08 | Anadys Pharmaceuticals Inc | Compostos e respectivos método de preparação, método de redução de composto de sulfonil substituído, composição farmacêutica método de tratamento ou prevenção de doença |
WO2009026292A1 (en) | 2007-08-20 | 2009-02-26 | Anadys Pharmaceuticals, Inc. | Dosing methods for treating disease |
AU2015359692B2 (en) | 2014-12-08 | 2020-07-09 | F. Hoffmann-La Roche Ag | 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection |
PL3270915T3 (pl) * | 2015-03-16 | 2020-08-24 | F. Hoffmann-La Roche Ag | Leczenie skojarzone z zastosowaniem agonisty tlr7 i inhibitora składania kapsydu hbv |
EP4001283A1 (en) | 2015-05-12 | 2022-05-25 | F. Hoffmann-La Roche AG | Substituted aminothiazolopyrimidinedione derivatives for the treatment and prophylaxis of virus infection |
CN107820498B (zh) | 2015-06-30 | 2020-06-19 | 豪夫迈·罗氏有限公司 | 用于治疗和预防病毒感染的取代的氨基噻唑并嘧啶二酮 |
CA3048768A1 (en) * | 2017-01-06 | 2018-07-12 | F. Hoffmann-La Roche Ag | Process for the preparation of 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds |
-
2018
- 2018-01-04 CA CA3048768A patent/CA3048768A1/en active Pending
- 2018-01-04 CN CN201880005928.5A patent/CN110139868B/zh active Active
- 2018-01-04 MX MX2019008116A patent/MX2019008116A/es unknown
- 2018-01-04 KR KR1020197021399A patent/KR102602328B1/ko active IP Right Grant
- 2018-01-04 US US16/476,165 patent/US11142534B2/en active Active
- 2018-01-04 EP EP18700181.3A patent/EP3568400A1/en active Pending
- 2018-01-04 AU AU2018205994A patent/AU2018205994B2/en active Active
- 2018-01-04 WO PCT/EP2018/050159 patent/WO2018127525A1/en unknown
- 2018-01-04 BR BR112019013884-6A patent/BR112019013884A2/pt unknown
- 2018-01-04 JP JP2019536123A patent/JP7201598B2/ja active Active
- 2018-01-05 TW TW107100418A patent/TWI808068B/zh active
-
2019
- 2019-07-02 IL IL267801A patent/IL267801B2/en unknown
-
2021
- 2021-10-29 AU AU2021258083A patent/AU2021258083A1/en not_active Abandoned
-
2022
- 2022-10-21 JP JP2022168922A patent/JP2023011699A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN110139868B (zh) | 2021-07-09 |
IL267801B1 (en) | 2023-03-01 |
IL267801A (en) | 2019-09-26 |
JP7201598B2 (ja) | 2023-01-10 |
AU2018205994B2 (en) | 2021-09-09 |
IL267801B2 (en) | 2023-07-01 |
CN110139868A (zh) | 2019-08-16 |
BR112019013884A2 (pt) | 2020-03-03 |
TW201829419A (zh) | 2018-08-16 |
EP3568400A1 (en) | 2019-11-20 |
US20200024287A1 (en) | 2020-01-23 |
KR102602328B1 (ko) | 2023-11-16 |
AU2018205994A1 (en) | 2019-06-13 |
AU2021258083A1 (en) | 2021-11-25 |
KR20190099492A (ko) | 2019-08-27 |
TWI808068B (zh) | 2023-07-11 |
JP2020504126A (ja) | 2020-02-06 |
US11142534B2 (en) | 2021-10-12 |
JP2023011699A (ja) | 2023-01-24 |
CA3048768A1 (en) | 2018-07-12 |
WO2018127525A1 (en) | 2018-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018009944A (es) | Procedimiento para la preparacion del acido 4-fenil-5-alcoxicarbon il-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]3-oxo-5,6,8,8a- tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxilico. | |
PH12017501061A1 (en) | 3-substituted 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection | |
MX2019008116A (es) | Proceso para la preparacion de compuestos de 5-amino-6h-tiazolo[4, 5-d]pirimidina-2,7-diona 3-sustituidos. | |
MD3601283T2 (ro) | Compus inhibitor JAK pe bază de imidazo-piperidină fuzionată | |
MX2009008338A (es) | Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio. | |
MX2020001235A (es) | Análogos de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona. | |
TN2015000293A1 (en) | Heterocycle-substituted tetracyclic compounds and methods of use thereof for treatment of viral diseases | |
MX2017012393A (es) | Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico. | |
MX2010007375A (es) | Nuevos derivados de lupano. | |
WO2008094909A3 (en) | Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions | |
DE60331056D1 (de) | 6-11 bicyclische ketolidderivate | |
MX2020008816A (es) | Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas. | |
MX2009003874A (es) | Derivados de espiro-oxindol triciclicos y sus usos como agentes terapeuticos. | |
MX2010007374A (es) | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. | |
WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
MX2022015703A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf. | |
PH12020552017A1 (en) | 2,3-dihydro-1h-pyrrolizine-7-formamide derivative and application thereof | |
MX2020012827A (es) | Compuestos tetrahidro-1h-pirazino[2,1-a]isoindolilquinolina para el tratamiento de enfermedades autoinmunes. | |
CR20210513A (es) | Compuestos de haxahidro 1-h-pirazino[1,2-a]pirazina para el tratamiento de una enfermedad autoinmunitaria | |
MX2021010122A (es) | Compuestos de imidazopiridinilo y su uso para el tratamiento de trastornos neurodegenerativos. | |
UY27577A1 (es) | Inhibidores de la integrasa del vih | |
MX2021012105A (es) | Compuestos de pirrol. | |
MX2022006333A (es) | Compuesto triheterociclico como inhibidor de jak y uso del mismo. | |
WO2008109856A3 (en) | Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions | |
MX2022002331A (es) | Nuevas formas solidas de acetato de[(1s)-1-[(2s,4r,5r)-5-(5-amino- 2-oxo-tiazolo[4,5-d]pirimidin-3-il)-4-hidroxi tetrahidrofuran-2-il]propilo]. |